News

Researchers show that the generalized immune-boosting properties of many vaccines can cross-protect patients against multiple pathogens.

Scientists have discovered an antibody that may lead to more effective treatments against a wide range of sarbecoviruses, the family of viruses that includes the coronavirus SARS-CoV-2 and their variants.

Researchers have explored a novel strategy to enhance the reprogramming efficiency of human fibroblasts into heart muscle.

SARS-CoV-2 antibodies are transferred from vaccinated mothers to their babies through breastmilk.

Scientists studied the sensitivity of the Omicron variant to monoclonal antibodies used in clinical practice to prevent severe forms of the disease in people at risk, as well as to antibodies in the blood of individuals previously infected with SARS-CoV-2 or vaccinated.

A study shows that the majority of people with inflammatory rheumatic and musculoskeletal diseases tolerate their COVID vaccine well – with no difference in safety profile to that seen in the general population.

A new study published in Obstetrics & Gynecology found that COVID-19 vaccination may cause a small change to the timing of the menstrual cycle, but that this change is temporary.

According to a new study, an experimental immunotherapy can temporarily reprogram patients’ immune cells to attack a specific target.

Self-spreading vaccines for animals intended to limit the spread of animal diseases or disease spillover to humans are being researched in Europe and the US.

An additional “booster” dose of Moderna or Pfizer mRNA-based vaccine is needed to provide immunity against the Omicron variant of SARS-CoV-2, the virus that causes COVID-19, according to a new study.